We performed ChIP analysis to demonstrate that MYCN binds to the BLM promoter in MYCN-amplified LA-N-1 and NB19 neuroblastoma cells, whereas the binding was not detected in non-MYCN-amplified SH-SY5Y cells (Fig. 4B). The gene discussed is MYCN; the disease is neuroblastoma.